Internal Medicine, Pulmonary Disease · Williamsville, NY
NPI
1114976313
Since 2006
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
295 Essjay Rd
Williamsville, NY, 14221
Phone (716) 857-8646
Groups this clinician bills Medicare through
Medicare paid, 2024
$68K
1,316 services
Medicare patients, 2024
582
Average age 74
Drug cost, 2024
$3.6M
8,022 prescriptions
Company payments, 2025
$1,239
From 6 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Sherif Sherif was code 99213 (office e&m - established), 446 times for 309 patients. In total Sherif Sherif billed 1,316 services in 14 codes, and Medicare paid $68K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-12-13.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 446 | 309 | $57.99 | $26K |
| 94060 Pulmonary Function Testing | Office | 222 | 221 | $27.37 | $6,075 |
| 94729 Pulmonary Function Testing | Office | 218 | 217 | $38.47 | $8,387 |
| 94726 Pulmonary Function Testing | Office | 200 | 200 | $39.10 | $7,819 |
| 99214 Office E&M - Established | Office | 131 | 105 | $83.44 | $11K |
| 99204 Office E&M - New | Office | 26 | 26 | $107.57 | $2,797 |
| 99291 Critical Care E&M | Facility | 22 | 17 | $159.18 | $3,502 |
| 99212 Office E&M - Established | Office | 22 | 20 | $32.84 | $722 |
| 99222 Hospital E&M - Initial | Facility | 11 | 11 | $87.40 | $961 |
By year: 2022 $89K for 1,598 services; 2023 $82K for 1,443 services; 2024 $68K for 1,316 services.
Medicare prescription drug claims, 2024
In 2024, the drug Sherif Sherif prescribed most often to Medicare patients was Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter), with 1,482 prescriptions and refills. In total Sherif Sherif wrote 8,022 Medicare prescriptions that cost $3.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 1,482 | 1,928 | 262 | $1.2M |
| Albuterol Sulfate Hfa Albuterol Sulfate | 1,050 | 1,257 | 391 | $43K |
| Omeprazole Generic | 745 | 1,680 | 198 | $10K |
| Prednisone Generic | 687 | 788 | 291 | $2,367 |
| Breo Ellipta Fluticasone/Vilanterol | 565 | 679 | 95 | $263K |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 481 | 714 | 110 | $97K |
| Famotidine Generic | 308 | 731 | 93 | $4,485 |
| Azithromycin Generic | 266 | 280 | 166 | $1,341 |
| Spiriva Respimat Tiotropium Bromide | 258 | 408 | 59 | $205K |
| Stiolto Respimat Tiotropium Br/Olodaterol Hcl | 240 | 346 | 52 | $159K |
| Pantoprazole Sodium Generic | 204 | 461 | 66 | $3,112 |
| Budesonide-Formoterol Fumarate Budesonide/Formoterol Fumarate | 162 | 216 | 37 | $42K |
| Symbicort Budesonide/Formoterol Fumarate | 160 | 235 | 44 | $51K |
| Wixela Inhub Fluticasone Propion/Salmeterol | 116 | 233 | 45 | $34K |
| Montelukast Sodium Generic | 102 | 201 | 22 | $1,150 |
Brand drugs: 4,305 claims; generic drugs: - claims; opioid claims: 17.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Sherif Sherif $1,239 ($1,239 in general payments such as food, travel and fees) from 6 companies. The largest payer was GlaxoSmithKline, LLC. with $283.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.